MedPath

Ultrasound Guided Infraclavicular Brachial Plexus Block Using Levo-bupivacaine Alone or Combined With Dexmedetomidine for Hand and Forearm Surgeries

Not Applicable
Completed
Conditions
Wrist
Acquired Deformity of Elbow
Hand
Forearm
Interventions
Drug: Levobupivacaine(chirocaine) plus dexmedetomidine(precedex)
Registration Number
NCT04729868
Lead Sponsor
Aswan University Hospital
Brief Summary

To evaluate the efficacy of levo-bupivacaine alone and with dexmedetomidine in Ultrasound guided infraclavicular brachial plexus block for hand and forearm surgeries as regard:

Onset of sensory and motor blockade. Duration of sensory and motor blockade.

Analgesic pain scores using the verbal rating scale (VRS) for pain. Duration of analgesia postoperative complications.

Detailed Description

Technique for ultrasound guided infraclavicular brachial plexus block:

Preliminary scan

* The patient is positioned supine with the arm abducted to 90°(or resting by their side if unable to do so).

* The probe is placed immediately medial to the coracoid process in the parasagittal plane.

* Identify the pectoralis major and minor muscles superficially and the axillary artery and vein(s) deep to this. The vein is usually caudad relative to the artery.

* The cords of the brachial plexus are seen as either hypoechoic or hyperechoic structures positioned around the axillary artery. The lateral cord is lateral (cephalad) to the artery, the medial cord medial (caudad),and the posterior cord posterior (deep). They can be difficult to visualize but are usually positioned closely to the artery.

Ultrasound settings

* Probe: high-frequency (\>10MHz) linear broadband probe.

* Settings: MB-resolution/general.

* Depth: 3-6cm.

* Orientation: parasagittal.

* Needle: 50-100mm depending on depth of plexus. Technique

* An in-plane approach is recommended, inserted from the cephalad end of the transducer.

* Needle tip visualization may be challenging as the needle angle can be quite steep.

* Prepare the skin with 0.5% chlorhexidine in 70% alcohol. Wait until the skin is dry.

* Anaesthetize the skin with a subcutaneous injection of 1% lidocaine at the point of needle insertion.

* The needle is first advanced posterolateral to the artery to deposit local anesthetic around the posterior cord, 5 o'clock position on artery.

* After careful aspiration LA is injected in small aliquots, observing the spread of the LA which ideally occurs behind and up both sides of the artery forming a 'U' shape around the artery, 1-9 o'clock around the artery.

* If medial (caudad) spread is not observed then reinsertion of the needle between the axillary artery and vein, adjacent to the medial cord may be required.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Age: 20-65 years old.
  • American society of anesthesiologist physical status (ASA): I-II.
  • Operation: forearm & hand surgeries.
Exclusion Criteria
  • Patients with chronic pain
  • Those using chronic analgesic medications
  • History of brachial plexus injury
  • Allergy to the study drugs
  • Hepatic or renal insufficiency or infection at the site of injection

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
group levo-bupivacaine plus 50µg dexmedetomidineLevobupivacaine(chirocaine) plus dexmedetomidine(precedex)Group B (20 patients): Anesthesia will be performed with 35 ml of 0.5% levo-bupivacaine plus 50µg dexmedetomidine under the guidance of ultrasound for infraclavicular brachial plexus block.
group levo-bupivacaine plus 100µg dexmedetomidineLevobupivacaine(chirocaine) plus dexmedetomidine(precedex)Group C (20 patients): Anesthesia will be performed with 35 ml of 0.5% levo-bupivacaine plus 100µg dexmedetomidine under the guidance of ultrasound for infraclavicular brachial plexus block.
group Levo-bupivacaineLevobupivacaine(chirocaine) plus dexmedetomidine(precedex)Group A (20 patients): Anesthesia will be performed with 35 ml of 0.5% levo-bupivacaine plus 1ml normal saline under the guidance of ultrasound for infraclavicular brachial plexus block.
Primary Outcome Measures
NameTimeMethod
Duration of sensory block in hours24 hours

It's the time from sensory block onset to the time of restoration of sensation at the surgical site

onset time of motor blockade in minutes using the modified Bromage scale (Three-point scale)24 hours

the modified Bromage scale (Three-point scale): Grade 0: Normal motor function, Grade 1: Decreased motor strength with the ability to move the fingers only, Grade 2: Complete motor block with an inability to move the fingers.

Onset time of sensory block in minutes45 minutes

After the injection of the solution, every patient was checked for the onset of sensory blockade using goose soaked with iced normal saline by the following scale (three-point scale): Grade 0= perceived as normal sensation, Grade 1 = loss of cold sensation (analgesia), Grade 2= loss of sensation of touch (anesthesia).

Duration of motor block in hours24 hours

It's the time from motor block onset to the restoration of global mobility in the hand and the wrist.

Secondary Outcome Measures
NameTimeMethod
heart rate in beats / minute24 hours

was measured before the block (0 min) and at 5, 10, 15, 30 min then 1, 2, 3, 6, 12,18and 24 h after the block.

Visual analog scale (VAS)24 hours

the VAS consisted of a straight, vertical 10-cm line; the bottom point represented "no pain" = (0 cm) and the top "the worst pain you ever have" = (10 cm)

Postoperative first analgesic request time in hours24 hours

was taken from the time of complete sensory block to the request to rescue analgesia when VAS \> 4 cm.

Mean blood pressure in mmHg24 hours

was measured before the block (0 min) and at 5, 10, 15, 30 min then 1, 2, 3, 6, 12,18and 24 h after the block

peripheral oxygen saturation24 hours

was measured before the block (0 min) and at 5, 10, 15, 30 min then 1, 2, 3, 6, 12,18and 24 h after the block.

Trial Locations

Locations (1)

Zaher

🇪🇬

Cairo, Egypt

Zaher
🇪🇬Cairo, Egypt
© Copyright 2025. All Rights Reserved by MedPath